NO970892L - Isoksazolderivater - Google Patents
IsoksazolderivaterInfo
- Publication number
- NO970892L NO970892L NO970892A NO970892A NO970892L NO 970892 L NO970892 L NO 970892L NO 970892 A NO970892 A NO 970892A NO 970892 A NO970892 A NO 970892A NO 970892 L NO970892 L NO 970892L
- Authority
- NO
- Norway
- Prior art keywords
- group
- ring
- integer
- alkylthio
- amino
- Prior art date
Links
- 150000002545 isoxazoles Chemical class 0.000 title abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 102000010909 Monoamine Oxidase Human genes 0.000 abstract 1
- 108010062431 Monoamine oxidase Proteins 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 230000007823 neuropathy Effects 0.000 abstract 1
- 201000001119 neuropathy Diseases 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20536394 | 1994-08-30 | ||
| JP15057195 | 1995-06-16 | ||
| PCT/JP1995/001714 WO1996006837A1 (en) | 1994-08-30 | 1995-08-29 | Isoxazoles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO970892D0 NO970892D0 (no) | 1997-02-27 |
| NO970892L true NO970892L (no) | 1997-04-29 |
| NO308741B1 NO308741B1 (no) | 2000-10-23 |
Family
ID=26480122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO970892A NO308741B1 (no) | 1994-08-30 | 1997-02-27 | Isoksazolderivater, mellomprodukter, farmasøytiske preparater og anvendelse av derivatene |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5965591A (no) |
| EP (1) | EP0779281B1 (no) |
| KR (1) | KR970705549A (no) |
| CN (1) | CN1098843C (no) |
| AT (1) | ATE253057T1 (no) |
| AU (1) | AU688102B2 (no) |
| CA (1) | CA2198457A1 (no) |
| CZ (1) | CZ290961B6 (no) |
| DE (1) | DE69532039T2 (no) |
| DK (1) | DK0779281T3 (no) |
| ES (1) | ES2208690T3 (no) |
| FI (1) | FI970864A7 (no) |
| HU (1) | HU221138B1 (no) |
| MX (1) | MX9701630A (no) |
| NO (1) | NO308741B1 (no) |
| NZ (1) | NZ291508A (no) |
| PT (1) | PT779281E (no) |
| RU (1) | RU2140414C1 (no) |
| WO (1) | WO1996006837A1 (no) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ291508A (en) * | 1994-08-30 | 1999-07-29 | Sankyo Co | Isoxazoles; preparation and medicaments |
| CA2247439A1 (en) * | 1996-02-27 | 1997-09-04 | Sankyo Company, Limited | Isoxazole derivatives |
| US6339099B1 (en) * | 1997-06-20 | 2002-01-15 | Dupont Pharmaceuticals Company | Guanidine mimics as factor Xa inhibitors |
| WO2000027199A1 (en) * | 1998-11-12 | 2000-05-18 | Eli Lilly And Company | Aminobenzisoxazole compounds and libraries thereof |
| US6497928B1 (en) | 1999-05-14 | 2002-12-24 | Canon Kabushiki Kaisha | Liquid crystal device, mesomorphic functional material and liquid crystal apparatus |
| DE10000577A1 (de) | 2000-01-10 | 2001-07-26 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten |
| US6638981B2 (en) * | 2001-08-17 | 2003-10-28 | Epicept Corporation | Topical compositions and methods for treating pain |
| US6660736B2 (en) * | 2002-03-27 | 2003-12-09 | Hoffmann-La Roche Inc. | Phthalimido derivatives and a process for their preparation |
| PA8583001A1 (es) * | 2002-09-20 | 2004-04-23 | Hoffmann La Roche | Derivados de 4-pirrolidino-fenil-bencil eter como inhibidores de mao-b |
| NZ548212A (en) * | 2003-12-29 | 2010-07-30 | Sepracor Inc | Pyrrole and pyrazole DAAO inhibitors |
| ZA200605384B (en) * | 2003-12-29 | 2007-10-31 | Sepracor Inc | Benzo[D]isoxazol-3-OL DAAO inhibitors |
| WO2005089753A2 (en) * | 2004-03-16 | 2005-09-29 | Janssen Pharmaceutica N.V. | Daao inhibiting bξnzisoxazoles and their use for the treatment of mental disorders |
| AU2005268894B2 (en) * | 2004-08-02 | 2010-12-16 | F. Hoffmann-La Roche Ag | Benzyloxy derivatives as MAOB inhibitors |
| DE102005018389A1 (de) * | 2005-04-20 | 2006-10-26 | Sanofi-Aventis Deutschland Gmbh | Azolderivate als Inhibitoren von Lipasen und Phospholipasen |
| WO2007006003A2 (en) | 2005-07-06 | 2007-01-11 | Sepracor Inc. | Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
| KR20080038369A (ko) * | 2005-07-28 | 2008-05-06 | 버텍스 파마슈티칼스 인코포레이티드 | 카스파제 억제제 프로드럭 |
| KR101294014B1 (ko) | 2006-01-06 | 2013-08-09 | 선오비온 파마슈티컬스 인코포레이티드 | 모노아민 재흡수 저해제로서의 시클로알킬아민 |
| US8053603B2 (en) * | 2006-01-06 | 2011-11-08 | Sunovion Pharmaceuticals Inc. | Tetralone-based monoamine reuptake inhibitors |
| RU2434002C2 (ru) * | 2006-02-21 | 2011-11-20 | Тояма Кемикал Ко., Лтд. | Способ получения сложного эфира 3-[5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-оксо-2-замещенный-2, 3-дигидро-1, 2-бензизоксазол-6-ил)метокси]фенил]пропионовой кислоты и промежуточного продукта для данного способа |
| DK2816024T3 (en) | 2006-03-31 | 2017-10-30 | Sunovion Pharmaceuticals Inc | CHIRALE AMINER |
| US7884124B2 (en) * | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
| US7579370B2 (en) * | 2006-06-30 | 2009-08-25 | Sepracor Inc. | Fused heterocycles |
| US20080082066A1 (en) * | 2006-10-02 | 2008-04-03 | Weyerhaeuser Co. | Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks |
| ES2627221T3 (es) | 2006-12-28 | 2017-07-27 | Rigel Pharmaceuticals, Inc. | Compuestos de heterocicloalquiloxibenzamida N-sustituidos y métodos de uso |
| US7902252B2 (en) * | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
| US20090099248A1 (en) * | 2007-01-18 | 2009-04-16 | Sepracor Inc. | Inhibitors of d-amino acid oxidase |
| MX2009012685A (es) | 2007-05-31 | 2009-12-14 | Sepracor Inc | Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina. |
| WO2009104080A2 (en) | 2008-02-20 | 2009-08-27 | Targia Pharmaceuticals | Cns pharmaceutical compositions and methods of use |
| WO2010017418A1 (en) * | 2008-08-07 | 2010-02-11 | Sepracor Inc. | Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| WO2011017634A2 (en) * | 2009-08-07 | 2011-02-10 | Sepracore Inc. | Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| MX2012009377A (es) | 2010-02-11 | 2012-09-12 | Univ Vanderbilt | Benzotiazoles y azabenzotiazoles como potenciadores alostericos mglur4, composiciones y metodos para tratar la disfuncion neurologica. |
| MX2014005304A (es) | 2011-10-31 | 2015-03-20 | Xenon Pharmaceuticals Inc | Biaril eter sulfonamidas y su uso como agentes terapeuticos. |
| ES2586213T3 (es) | 2011-10-31 | 2016-10-13 | Xenon Pharmaceuticals Inc. | Compuestos de bencenosulfonamida y su uso como agentes terapéuticos |
| CA2874621A1 (en) | 2012-05-22 | 2013-11-28 | Genentech, Inc. | N-substituted benzamides and their use in the treatment of pain |
| US10071957B2 (en) | 2012-07-06 | 2018-09-11 | Genentech, Inc. | N-substituted benzamides and methods of use thereof |
| CN105263490B (zh) | 2013-03-14 | 2018-05-22 | 基因泰克公司 | 取代的三唑并吡啶及其使用方法 |
| CA2898680A1 (en) | 2013-03-15 | 2014-09-18 | Genentech,Inc. | Substituted benzoxazoles and methods of use thereof |
| JP6383418B2 (ja) | 2013-11-27 | 2018-08-29 | ジェネンテック， インコーポレイテッド | 置換ベンズアミド及びその使用方法 |
| CN106715418A (zh) | 2014-07-07 | 2017-05-24 | 基因泰克公司 | 治疗化合物及其使用方法 |
| MA42118A (fr) | 2015-05-22 | 2018-03-28 | Genentech Inc | Benzamides substitués et leurs méthodes d'utilisation |
| WO2017035271A1 (en) | 2015-08-27 | 2017-03-02 | Genentech, Inc. | Therapeutic compounds and methods of use thereof |
| US10899732B2 (en) | 2015-11-25 | 2021-01-26 | Genentech, Inc. | Substituted benzamides useful as sodium channel blockers |
| US10766858B2 (en) | 2016-03-30 | 2020-09-08 | Genentech, Inc. | Substituted benzamides and methods of use thereof |
| CN105801510A (zh) * | 2016-04-08 | 2016-07-27 | 李勇 | 一种治疗抑郁症的药物组合物 |
| BR112019007763A2 (pt) | 2016-10-17 | 2019-07-02 | Genentech Inc | composto de fórmula, composição farmacêutica, métodos para tratar uma doença ou condição, para tratar dores, para diminuir o fluxo de íons e para tratar prurido, uso de um composto e invenção |
| EP3601273B1 (en) | 2017-03-24 | 2021-12-01 | Genentech, Inc. | 4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors |
| AR114263A1 (es) | 2018-02-26 | 2020-08-12 | Genentech Inc | Compuestos terapéuticos y métodos para utilizarlos |
| WO2019191702A1 (en) | 2018-03-30 | 2019-10-03 | F. Hoffmann-La Roche Ag | Substituted hydro-pyrido-azines as sodium channel inhibitors |
| TW202003490A (zh) | 2018-05-22 | 2020-01-16 | 瑞士商赫孚孟拉羅股份公司 | 治療性化合物及其使用方法 |
| CN114349690B (zh) * | 2022-02-15 | 2023-04-25 | 甘肃皓天医药科技有限责任公司 | 一种多拉韦林中间体合成方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1265824A (no) * | 1968-03-28 | 1972-03-08 | ||
| SU539522A3 (ru) * | 1970-02-05 | 1976-12-15 | Мерк Энд Ко. Инк. (Фирма) | Способ получени гидразин- -фенилпропионовой кислоты |
| US3812187A (en) * | 1970-02-05 | 1974-05-21 | Merck & Co Inc | Hydrazides |
| JPS476302Y1 (no) * | 1970-06-08 | 1972-03-04 | ||
| US5321037A (en) * | 1986-12-26 | 1994-06-14 | Sankyo Company, Limited | Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants |
| IE62276B1 (en) * | 1988-03-30 | 1995-01-25 | Sankyo Co | "New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants" |
| US5116839A (en) * | 1989-06-26 | 1992-05-26 | Sankyo Company, Limited | Use of isoxazolin-3-one derivatives as antidepressants |
| US5352688A (en) * | 1991-02-14 | 1994-10-04 | The Mount Sinai School Of Medicine Of The City University Of New York | Methods for the treatment of bradyphrenia in parkinson's disease |
| US5750542A (en) * | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
| JPH0588630A (ja) * | 1991-09-30 | 1993-04-09 | Toshiba Lighting & Technol Corp | 表示装置 |
| CA2146755A1 (en) * | 1992-10-28 | 1994-05-11 | Kenji Takeda | Novel 1,2-benzoisoxazole derivative or its salt and brain-protecting agent comprising the same |
| US5494908A (en) * | 1992-11-23 | 1996-02-27 | Hoechst-Roussel Pharmaceutical Incorporated | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| NZ291508A (en) * | 1994-08-30 | 1999-07-29 | Sankyo Co | Isoxazoles; preparation and medicaments |
| CA2190708A1 (en) * | 1995-12-08 | 1997-06-09 | Johannes Aebi | Aminoalkyl substituted benzo-heterocyclic compounds |
| JP5229734B2 (ja) * | 2008-11-26 | 2013-07-03 | 住化エンビロサイエンス株式会社 | 木材保存組成物 |
-
1995
- 1995-08-29 NZ NZ291508A patent/NZ291508A/xx unknown
- 1995-08-29 WO PCT/JP1995/001714 patent/WO1996006837A1/ja not_active Ceased
- 1995-08-29 CN CN95195758A patent/CN1098843C/zh not_active Expired - Fee Related
- 1995-08-29 CA CA002198457A patent/CA2198457A1/en not_active Abandoned
- 1995-08-29 KR KR1019970701279A patent/KR970705549A/ko not_active Abandoned
- 1995-08-29 AT AT95929249T patent/ATE253057T1/de not_active IP Right Cessation
- 1995-08-29 DE DE69532039T patent/DE69532039T2/de not_active Expired - Fee Related
- 1995-08-29 PT PT95929249T patent/PT779281E/pt unknown
- 1995-08-29 ES ES95929249T patent/ES2208690T3/es not_active Expired - Lifetime
- 1995-08-29 EP EP95929249A patent/EP0779281B1/en not_active Expired - Lifetime
- 1995-08-29 DK DK95929249T patent/DK0779281T3/da active
- 1995-08-29 HU HU9701740A patent/HU221138B1/hu not_active IP Right Cessation
- 1995-08-29 AU AU32660/95A patent/AU688102B2/en not_active Ceased
- 1995-08-29 MX MX9701630A patent/MX9701630A/es unknown
- 1995-08-29 RU RU97103132/04A patent/RU2140414C1/ru not_active IP Right Cessation
- 1995-08-29 CZ CZ1997598A patent/CZ290961B6/cs not_active IP Right Cessation
-
1997
- 1997-02-26 US US08/806,854 patent/US5965591A/en not_active Expired - Fee Related
- 1997-02-27 NO NO970892A patent/NO308741B1/no unknown
- 1997-02-28 FI FI970864A patent/FI970864A7/fi not_active IP Right Cessation
-
1999
- 1999-02-03 US US09/243,885 patent/US6096771A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0779281A1 (en) | 1997-06-18 |
| DE69532039D1 (de) | 2003-12-04 |
| RU2140414C1 (ru) | 1999-10-27 |
| EP0779281B1 (en) | 2003-10-29 |
| HU221138B1 (en) | 2002-08-28 |
| ES2208690T3 (es) | 2004-06-16 |
| ATE253057T1 (de) | 2003-11-15 |
| US6096771A (en) | 2000-08-01 |
| DK0779281T3 (da) | 2004-03-08 |
| AU688102B2 (en) | 1998-03-05 |
| FI970864A7 (fi) | 1997-04-24 |
| CN1098843C (zh) | 2003-01-15 |
| NO970892D0 (no) | 1997-02-27 |
| CZ59897A3 (en) | 1997-07-16 |
| HUT77225A (hu) | 1998-03-02 |
| HK1018878A1 (en) | 2000-01-07 |
| WO1996006837A1 (en) | 1996-03-07 |
| CA2198457A1 (en) | 1996-03-07 |
| AU3266095A (en) | 1996-03-22 |
| CN1162957A (zh) | 1997-10-22 |
| EP0779281A4 (en) | 2000-07-26 |
| US5965591A (en) | 1999-10-12 |
| DE69532039T2 (de) | 2004-07-08 |
| MX9701630A (es) | 1997-06-28 |
| CZ290961B6 (cs) | 2002-11-13 |
| NO308741B1 (no) | 2000-10-23 |
| KR970705549A (ko) | 1997-10-09 |
| NZ291508A (en) | 1999-07-29 |
| FI970864A0 (fi) | 1997-02-28 |
| PT779281E (pt) | 2004-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU688102B2 (en) | Isoxazoles | |
| ATE180468T1 (de) | Anthranilsäure derivate | |
| ATE286026T1 (de) | Amid-derivate und deren medizinische verwendung | |
| NZ330973A (en) | Azolobenzazepine derivatives as neurologically active agents | |
| NO20020968L (no) | Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
| AU5162396A (en) | Protective agent for organ or tissue | |
| NZ334701A (en) | Dihydropyrones and use in treating retrovirus infections and diseases | |
| EP0885891A4 (en) | ISOXAZOLE DERIVATIVES | |
| ZA200110138B (en) | Benzamide derivatives, insecticides for agricultural and horticultural use and usage thereof. | |
| EP1034783A4 (en) | AMIDE DERIVATIVES | |
| EP0889033A4 (no) | ||
| GR3036029T3 (en) | Optically active thiazolidinone derivatives | |
| NO20012443D0 (no) | Benzoksazolderivater og legemidler inneholdende disse som aktiv bestanddel | |
| DE68926418D1 (de) | S'-adenosyl-methionin-decarboxylase-Inhibitoren | |
| ES2168119T3 (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
| EP0785193A4 (en) | ARYLTHIADIAZOLE DERIVATIVE AND ANTIVIRAL AGENT CONTAINING THE SAME | |
| AU6118798A (en) | Remedies for peripheral circulation disturbances |